Sulfonylureas show unfavourable risk profiles

By  

Reactions Weekly, Vol. 1, Iss. 1283, 2010-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Rofecoxib cost-effectiveness study results debated

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 455, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

A Cost-Effectiveness Analysis to Illustrate the Impact of Cost Definitions on Results, Interpretations and Comparability of Pharmacoeconomic Studies in the US

By Tunis Sandra L.  

PharmacoEconomics, Vol. 27, Iss. 9, 2009-09 ,pp. : 735-744

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Interventions for Lateral Epicondylitis: Results from a Randomised Controlled Trial in Primary Care

By Bos I.B.C.K-d.  

PharmacoEconomics, Vol. 22, Iss. 3, 2004-01 ,pp. : 185-195

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Early Lisinopril Use in Patients With Acute Myocardial Infarction: Results From GISSI-3 Trial

By Franzosi M.G.   Maggioni A.P.   Santoro E.   Tognoni G.   Cavalieri E.  

PharmacoEconomics, Vol. 13, Iss. 3, 1998-03 ,pp. : 337-346

Adis International

Access to resources Recommend Favorite